Cargando…
Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
Although cytoplasmic AMP-activated protein kinase (AMPK) has been known as a tumor-suppressor protein, nuclear AMPK is suggested to support clear cell renal cell carcinoma (ccRCC). In addition, pAMPK interacts with TGF-β/SMAD, which is one of the frequently altered pathways in ccRCC. In this study,...
Autores principales: | Jung, Minsun, Lee, Jeong Hoon, Lee, Cheol, Park, Jeong Hwan, Park, Yu Rang, Moon, Kyung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826619/ https://www.ncbi.nlm.nih.gov/pubmed/31640193 http://dx.doi.org/10.3390/cancers11101602 |
Ejemplares similares
-
Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2013) -
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance
por: Liu, Yuan, et al.
Publicado: (2021) -
Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis
por: Picher-Martel, Vincent, et al.
Publicado: (2023) -
Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study
por: Lee, Seokhyeon, et al.
Publicado: (2023) -
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)